JP2005524670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005524670A5 JP2005524670A5 JP2003574168A JP2003574168A JP2005524670A5 JP 2005524670 A5 JP2005524670 A5 JP 2005524670A5 JP 2003574168 A JP2003574168 A JP 2003574168A JP 2003574168 A JP2003574168 A JP 2003574168A JP 2005524670 A5 JP2005524670 A5 JP 2005524670A5
- Authority
- JP
- Japan
- Prior art keywords
- hours
- carbidopa
- time
- water contact
- rapid release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960004205 carbidopa Drugs 0.000 claims 1
- TZFNLOMSOLWIDK-JTQLQIEISA-N carbidopa (anhydrous) Chemical compound NN[C@@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 TZFNLOMSOLWIDK-JTQLQIEISA-N 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36182102P | 2002-03-04 | 2002-03-04 | |
| US29161902A | 2002-11-12 | 2002-11-12 | |
| PCT/US2003/006591 WO2003075893A1 (en) | 2002-03-04 | 2003-03-03 | Controlled release dosage forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005524670A JP2005524670A (ja) | 2005-08-18 |
| JP2005524670A5 true JP2005524670A5 (https=) | 2006-04-13 |
Family
ID=27807664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003574168A Pending JP2005524670A (ja) | 2002-03-04 | 2003-03-03 | 放出制御投与形態 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1492508A4 (https=) |
| JP (1) | JP2005524670A (https=) |
| KR (1) | KR20100049695A (https=) |
| CN (1) | CN1649569B (https=) |
| AU (2) | AU2003217909C1 (https=) |
| BR (1) | BR0308305A (https=) |
| CA (1) | CA2477701A1 (https=) |
| EA (1) | EA005866B1 (https=) |
| IL (1) | IL163887A0 (https=) |
| MX (1) | MXPA04008536A (https=) |
| NO (1) | NO20044188L (https=) |
| NZ (1) | NZ535083A (https=) |
| WO (1) | WO2003075893A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
| AU2003249478A1 (en) * | 2002-07-19 | 2004-02-09 | Ranbaxy Laboratories Limited | Taste masked sumatriptan tablets and processes for their preparation |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| US20040122065A1 (en) * | 2002-11-12 | 2004-06-24 | Lerner E. Itzhak | Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccally |
| CN100410063C (zh) * | 2003-11-14 | 2008-08-13 | 株式会社三和化学研究所 | 有核成型品的制造方法 |
| GB0400452D0 (en) * | 2004-01-09 | 2004-02-11 | Norton Healthcare Ltd | A pharmaceutical composition |
| GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
| CA2555406A1 (en) * | 2004-02-19 | 2005-09-01 | Teva Pharmaceutical Industries, Ltd. | Improved therapy using a combination of raloxifene and alendronate |
| KR100701409B1 (ko) | 2004-11-26 | 2007-03-30 | 한국유나이티드제약 주식회사 | 호박산 수마트립탄을 함유하는 약제학적 조성물 |
| CN102202656A (zh) | 2008-08-15 | 2011-09-28 | 蒂宝制药公司 | 治疗和预防cns障碍的胃滞留药用组合物 |
| CN110368371A (zh) * | 2014-04-08 | 2019-10-25 | 越洋医药开发(广州)有限公司 | 一种新型控释片 |
| JP6878417B2 (ja) * | 2016-02-17 | 2021-05-26 | トリアステック インコーポレイテッド | 剤形およびそれらの使用 |
| CN110604724A (zh) * | 2019-10-22 | 2019-12-24 | 恒诚制药集团淮南有限公司 | 一种肠溶美沙拉秦缓释片剂及其制备方法 |
| US12543731B2 (en) | 2022-10-13 | 2026-02-10 | Clarke Mosquito Control Products, Inc. | Insecticidal tablet compositions |
| JP2024083720A (ja) * | 2022-12-12 | 2024-06-24 | パナソニックＩｐマネジメント株式会社 | 水処理用徐放性固形薬剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB972128A (en) * | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
| JPS61243016A (ja) * | 1985-04-19 | 1986-10-29 | Katsumi Takada | 柱状の有効成分含有部分をもつ錠剤 |
| GB8514666D0 (en) * | 1985-06-11 | 1985-07-10 | Coopers Animal Health | Agent delivery systems |
| JPS6253918A (ja) * | 1985-09-02 | 1987-03-09 | Katsumi Takada | 柱状の有効成分含有部分を埋没させた錠剤 |
| DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
| US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
| JP3962108B2 (ja) * | 1995-04-03 | 2007-08-22 | 中外製薬株式会社 | スクラルファート含有製剤組成物 |
| CA2184316A1 (en) * | 1995-09-12 | 1997-03-13 | Wei-Chi Liao | Buccal delivery system for therapeutic agents |
| ATE214597T1 (de) * | 1997-12-19 | 2002-04-15 | Merck Patent Gmbh | Mehrschichttablette enthaltend probiotische mikroorganismen wie z.b. lactobacilli oder bifidobakterien |
| BR9813728A (pt) * | 1997-12-22 | 2000-10-10 | Schering Corp | Composição de dispersão molecular com elevada biodisponibilidade |
| JP4748839B2 (ja) * | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | シロスタゾール製剤 |
| US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
| MXPA03000194A (es) * | 2000-06-28 | 2004-09-13 | Angiogenix Inc | Formulaciones de arginina de liberacion controlada. |
| KR100897837B1 (ko) * | 2001-12-24 | 2009-05-15 | 테바 파마슈티컬 인더스트리즈 리미티드 | 분말 또는 과립 물질의 압착된 환상체 내에 싸인 활성성분의 코어 정제를 갖는 제형과, 이의 제조 방법 및 툴링 |
-
2003
- 2003-03-03 EP EP03713882A patent/EP1492508A4/en not_active Withdrawn
- 2003-03-03 MX MXPA04008536A patent/MXPA04008536A/es active IP Right Grant
- 2003-03-03 EA EA200401097A patent/EA005866B1/ru not_active IP Right Cessation
- 2003-03-03 IL IL16388703A patent/IL163887A0/xx unknown
- 2003-03-03 CN CN038101068A patent/CN1649569B/zh not_active Expired - Fee Related
- 2003-03-03 NZ NZ535083A patent/NZ535083A/en not_active IP Right Cessation
- 2003-03-03 WO PCT/US2003/006591 patent/WO2003075893A1/en not_active Ceased
- 2003-03-03 AU AU2003217909A patent/AU2003217909C1/en not_active Ceased
- 2003-03-03 BR BR0308305-5A patent/BR0308305A/pt not_active IP Right Cessation
- 2003-03-03 KR KR1020107008536A patent/KR20100049695A/ko not_active Ceased
- 2003-03-03 JP JP2003574168A patent/JP2005524670A/ja active Pending
- 2003-03-03 CA CA002477701A patent/CA2477701A1/en not_active Abandoned
-
2004
- 2004-10-01 NO NO20044188A patent/NO20044188L/no not_active Application Discontinuation
-
2009
- 2009-01-30 AU AU2009200353A patent/AU2009200353A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005524670A5 (https=) | ||
| JP2006503588A5 (https=) | ||
| NO2018029I1 (no) | Alogliptin i kombinasjon med metformin, hver eventuelt i form av et farmasøytisk akseptabelt salt derav | |
| NO20053245D0 (no) | Tabletter med modifisert frigjoring av bupropionhydroklorid. | |
| JP2006524283A5 (https=) | ||
| JP2007520565A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| ZA200704661B (en) | Solid, orally appliance pharmaceutical administration forms containing rivaroxaban having modified release | |
| JP2006507281A5 (https=) | ||
| JP2006516528A5 (https=) | ||
| JP2010507682A5 (https=) | ||
| JP2006517944A5 (https=) | ||
| JP2009524695A5 (https=) | ||
| JP2007522094A5 (https=) | ||
| JP2004534810A5 (https=) | ||
| RU2002107079A (ru) | Вещество, обладающее седативным действием | |
| JP2002240244A5 (https=) | ||
| JP2008519810A5 (https=) | ||
| JP2006342148A5 (https=) | ||
| JP2007508806A5 (https=) | ||
| RU2003120857A (ru) | Адаптогенное средство | |
| JP2004224775A5 (https=) | ||
| JP2005531640A5 (https=) | ||
| JP2007119348A5 (https=) | ||
| RU2006124991A (ru) | Каблук |